Volume : 09, Issue : 11, November – 2022
Title:
39.NANOSPONGE: AN INNOVATIVE APPROACHES FOR CANCER THERAPY
Authors :
Makne P.D.*, Sameer Shafi, Sameena Shaikh
Abstract :
Nanosponges (NS) with three-dimensional (3D) porous structures, slim size distribution, and high defense potency square measure wide built for cancer medical care and drug delivery functions. They defend the molecular agents from degradation and facilitate to enhance the solubility of oleophilic therapeutic agents/drugs with targeted delivery choices additionally to being attractable to achieve appropriate magnetic options. Nanosponge-based delivery systems are applied for cancer medical care with high specificity, biocompatibility, degradability, and prolonged unharness behavior. several anti-cancer medicine with each deliquescent and oleophilic properties will be loaded or integrated into NS and ultimately increase the characteristics of the medicine. the foremost necessary properties and blessings of NS square measure simply synthesized and modified, offer high drug loading capability together with controlled unharness, increase the solubility and bioavailability of soluble molecules. The eco-friendly techniques for the producing of Nanosponges still have to be compelled to be uncovered additionally to the present ways, like solvent techniques, ultrasound assisted preparation, melting methods, and emulsion solvent diffusion ways. Herein, the recent advancements related to the drug delivery and cancer medical care potential of Nanosponges (chiefly cyclodextrin-based, DNAzyme, and alkyl radical polysaccharide Nanosponges) square measure deliberated, specializing in the necessary challenges and future views. During this critique, application of nanosponges, its preparation ways, polymers used and Cancer medical care were mentioned.
Keywords: – Nanosponges, Cancer, Biocompatibility, Ultrasound, Cyclodextrin, etc.
Cite This Article:
Please cite this article in press Makne Priti D et al, Nanosponge: An Innovative Approaches For Cancer Therapy., Indo Am. J. P. Sci, 2022; 09(11).
Number of Downloads : 10
References:
2. Pandey P, Purohit D, Dureja H. Nanosponges -A Promising Novel Drug Delivery System. Recent Pat Nanotechnology. 2018; 12(3):180-191. Doi: 10.2174/1872210512666180925102842. PMID: 30251614.
3. S.S, S A, Krishnamoorthy K, Rajappan M. Nanosponges: a novel class of drug delivery system–review. J Pharm Sci. 2012; 15(1):103-11. Doi: 10.18433/j3k308. PMID: 22365092
4. Tiwari, K.; Bhattacharya, S. The ascension of nanosponges as a drug delivery carrier: Preparation, characterization, and
5. Applications. J. Mater. Sci. Mater. Med. 2022, 33, 28.
6. Utzeri, G.; Matias, P.M.C.; Murtinho, D.; Valente, A.J.M. Cyclodextrin-based nanosponges: Overview and opportunities. Front.Chem. 2022, 10, 859406.
7. Allahyari, S.; Zahednezhad, F.; Khatami, M.; Hashemzadeh, N.; Zakeri-Milani, P.; Trotta, F. Cyclodextrin nanosponges as potential anticancer drug delivery systems to be introduced into the market, compared with liposomes. J. Drug Deliv. Sci.Technol. 2022, 67, 102931.
8. Wang, J.; Yu, S.; Wu, Q.; Gong, X.; He, S.; Shang, J.; Liu, X.; Wang, F. A self-catabolic multifunctional DNAzyme nanosponge for programmable drug delivery and efficient gene silencing. Angew Chem. 2021, 60, 10766–10774.
9. Wang, J.; Wang, H.; Wang, H.; He, S.; Li, R.; Deng, Z.; Liu, X.; Wang, F. Nonviolent Self-Catabolic DNAzyme Nanosponges for Smart Anticancer Drug Delivery. ACS Nano 2019, 13, 5852–5863.
10. B. Syed Salman and B. Thabitha. A review on Nanosponges. Global J Pharm Bio Sci. 2017; 2(1); 01-08.
11. Dadwal A, Baldi A, Narang RK. Nanoparticles as carriers for drug delivery in cancer. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):295–305. Doi: 10.1080/21691401.2018.1457039.
12. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA. 1998; 95(8):4607–4612. Doi: 10.1073/pnas.95.8.4607.
13. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Pathology: cancer cells compress intratumour vessels. Nature. 2004; 427(6976):695. Doi: 10.1038/427695a.
14. Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. Retrieved July 29, 2021, from 10.1111/jphp.13098.
15. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008; 60(15):1615–1626. Doi: 10.1016/j.addr.2008.08.005.